Home2019-03-27T07:27:50-07:00

Replace dolutegravir (Tivicay) with raltegravir (Isentress) for post-exposure prophylaxis

Post-exposure prophylaxis (PEP) of patients who may have been exposed [+]

By |Aug 10, 2018|Categories: Infectious Disease, Tox & Medications|0 Comments
Shuhan He, MD
ALiEM Senior Systems Engineer;
Director of Growth, Strategic Alliance Initiative, Center for Innovation and Digital Health
Massachusetts General Hospital;
Chief Scientific Officer, Conductscience.com
Shuhan He, MD
Go to Top